These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15296950)

  • 61. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P; Mäger I; Langel Ü
    Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos.
    Kristensen M; Birch D; Mørck Nielsen H
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840305
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Membrane permeable peptide vectors: chemistry and functional design for the therapeutic applications.
    Futaki S
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):447. PubMed ID: 18077052
    [No Abstract]   [Full Text] [Related]  

  • 64. Therapeutic applications of cell-penetrating peptides.
    Johnson RM; Harrison SD; Maclean D
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [TBL] [Abstract][Full Text] [Related]  

  • 65. S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells.
    Padari K; Koppel K; Lorents A; Hällbrink M; Mano M; Pedroso de Lima MC; Pooga M
    Bioconjug Chem; 2010 Apr; 21(4):774-83. PubMed ID: 20205419
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of cell-penetrating peptides for drug delivery.
    Temsamani J; Vidal P
    Drug Discov Today; 2004 Dec; 9(23):1012-9. PubMed ID: 15574317
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Investigation of the intracellular delivery of fluoresceinated peptides by a host-[2]rotaxane.
    Wang X; Bao X; McFarland-Mancini M; Isaacsohn I; Drew AF; Smithrud DB
    J Am Chem Soc; 2007 Jun; 129(23):7284-93. PubMed ID: 17516642
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
    Young Kim H; Young Yum S; Jang G; Ahn DR
    Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD.
    Watkins CL; Brennan P; Fegan C; Takayama K; Nakase I; Futaki S; Jones AT
    J Control Release; 2009 Dec; 140(3):237-44. PubMed ID: 19409429
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative.
    Itakura S; Hama S; Ikeda H; Mitsuhashi N; Majima E; Kogure K
    FEBS J; 2015 Jan; 282(1):142-52. PubMed ID: 25315678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems.
    Freire JM; Veiga AS; de la Torre BG; Andreu D; Castanho MA
    J Pept Sci; 2013 Apr; 19(4):182-9. PubMed ID: 23322613
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lipid vector for the delivery of peptides towards intracellular pharmacological targets.
    Gras-Masse H
    J Mol Recognit; 2003; 16(5):234-9. PubMed ID: 14523934
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides.
    Said Hassane F; Saleh AF; Abes R; Gait MJ; Lebleu B
    Cell Mol Life Sci; 2010 Mar; 67(5):715-26. PubMed ID: 19898741
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transduction peptides: from technology to physiology.
    Joliot A; Prochiantz A
    Nat Cell Biol; 2004 Mar; 6(3):189-96. PubMed ID: 15039791
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Potential of cell penetrating peptides for cell drug delivery].
    Poillot C; De Waard M
    Med Sci (Paris); 2011 May; 27(5):527-34. PubMed ID: 21609675
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Translocation mechanism(s) of cell-penetrating peptides: biophysical studies using artificial membrane bilayers.
    Di Pisa M; Chassaing G; Swiecicki JM
    Biochemistry; 2015 Jan; 54(2):194-207. PubMed ID: 25490050
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Cell penetrating peptides in cancer therapy].
    Huang S; Liu YW; Jiang Y
    Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):301-6. PubMed ID: 18232298
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reviewing biophysical and cell biological methodologies in cell-penetrating peptide (CPP) research.
    Herbig ME; Weller KM; Merkle HP
    Crit Rev Ther Drug Carrier Syst; 2007; 24(3):203-55. PubMed ID: 17956214
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Application of membrane-active peptides in the intracellular targeting drug delivery system].
    Sun X; Zhang ZR
    Yao Xue Xue Bao; 2002 Aug; 37(8):663-7. PubMed ID: 12567786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.